Chimeric Antigen Receptor T-cell Therapy for Chronic Lymphocytic Leukemia: What is the supporting evidence so far? [0.03%]
嵌合抗原受体T细胞治疗慢性淋巴细胞性白血病的循证依据是什么？
Razan Mohty,Shaykha Alotaibi,Martha Gadd et al.
Razan Mohty et al.
While acknowledging that newer therapies have improved survival rates in chronic lymphocytic leukemia (CLL), patients with high-risk disease features are at an increased risk of treatment failure. Allogeneic hematopoietic cell transplantati...
Risks and benefits of cannabis as a pain control modality in patients with sickle cell disease [0.03%]
镰状细胞病患者使用大麻作为止痛手段的风险和益处
Jeremy W Jacobs,Brian D Adkins,Laura D Stephens et al.
Jeremy W Jacobs et al.
Ke Xu,Charalampia Kyriakou
Ke Xu
Transfusion Support in Hematopoietic Stem Cell Transplantation: A Contemporary Narrative Review [0.03%]
造血干细胞移植中的输血支持：一项当代叙述性综述
Brian D Adkins,Jeremy W Jacobs,Garrett S Booth et al.
Brian D Adkins et al.
Hematopoietic stem cell transplantation (HSCT) is a cornerstone of modern medical practice, and can only be performed safely and effectively with appropriate transfusion medicine support. Patients undergoing HSCT often develop therapy-relat...
Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact [0.03%]
单倍型相合造血干细胞移植后环磷酰胺和抗胸腺细胞免疫球蛋白移植物抗宿主病预防下人类第六型疱疹病毒再活化的危险因素及临床影响
Annalisa Paviglianiti,Tânia Maia,Joël-Meyer Gozlan et al.
Annalisa Paviglianiti et al.
Human herpesvirus type 6 (HHV6) reactivation after haploidentical hematopoietic cell transplantation (HCT) with post-transplant cyclophosphamide (PT-Cy) has been scarcely studied, especially when antithymocyte globulin (ATG) is added to the...
Mohamad Mohty,S Vincent Rajkumar
Mohamad Mohty
Tolerability of Daratumumab Amongst Asian Patients with Plasma Cell Dyscrasias - A Single Centre Experience [0.03%]
daratumumab治疗亚洲浆细胞异常患者的耐受性：一项单中心研究
Allison C Y Tso,Samuel S Y Wang,Christian A Gallardo et al.
Allison C Y Tso et al.
Daratumumab is increasingly incorporated into the standard treatment regimens for patients with plasma cell dyscrasias in Asia, especially with cost-containment measures implemented by various regional health authorities. This analysis aime...
Celebrating five years of "Hematology without Borders" by the International Academy for Clinical Hematology (IACH) [0.03%]
国际临床血液学研究院(IACH)庆祝"无界血液学"五周年纪念日
Mohamad Mohty,Arnon Nagler,Bipin Savani
Mohamad Mohty
A Retrospective Review of Secondary Hemophagocytic Lymphohistiocytosis (HLH) and Dengue-associated HLH from a Teaching Hospital in Singapore [0.03%]
新加坡教学医院继发性噬血细胞性淋巴组织细胞增生症(HLH)和登革热相关HLH病例的回顾性研究
Allison C Y Tso,Sanchalika Acharyya,Sing Zern Fong et al.
Allison C Y Tso et al.
Real-world data on the outcome of Asian patients with secondary hemophagocytic lymphohistiocytosis (HLH), especially on dengue-associated HLH, are limited to small case series. This is a retrospective records review of adult patients with s...
Sinus bradycardia as a rare adverse event in patients receiving cyclosporine A after allogeneic hematopoietic stem cell transplantation [0.03%]
allo-HSCT后接受环孢素A治疗患者出现窦性心动过缓的一项罕见不良反应
Magdalena Karasek,Maciej Majcherek,Bartłomiej Kuszczak et al.
Magdalena Karasek et al.
Cyclosporine A (CSA) is a commonly used immunosuppressive agent for the prophylaxis of graft-versus-host disease following allogeneic hematopoietic stem cell transplantation (alloHSCT). While tachycardia is a known adverse effect of CSA, br...